The Annals of Internal Medicine publication “Trends in Cancer Incidence in Younger and Older Adults: An International Comparative Analysis” by Amy Berrington de González and colleagues provides the most comprehensive global evaluation to date of cancer trends across generations.
Using high-quality registry data from the International Agency for Research on Cancer’s (IARC) GLOBOCAN database, the study analyzed 13 major cancer types across 42 countries from 2003 to 2017, comparing incidence in younger adults (ages 20–49) and older adults (≥50 years).
Its companion editorial, “Generations at Risk: Unveiling the Global Increase in Cancer at Both Ends of Adulthood” by Christopher Cann and Efrat Dotan, contextualizes these findings and calls for generationally sensitive cancer prevention, treatment, and research strategies.
Main Findings of the Research Study
Berrington de González et al. confirmed a broad rise in cancer incidence across multiple types, noting that increases were not confined to younger adults. Among the 13 cancers examined, six showed consistent increases in younger adults across more than 75% of the participating countries—thyroid, breast, colorectal, kidney, endometrial cancer, and leukemia. The median annual increase (average annual percentage change, AAPC) ranged from 0.78% for leukemia to 3.57% for thyroid cancer. Importantly, apart from colorectal cancer, these same cancers also rose in older adults, suggesting shared etiologic drivers across age groups rather than a unique early-onset cancer epidemic
Colorectal cancer emerged as an outlier, increasing faster in younger adults in 69% of countries and showing statistically significant differences in over one-third. This divergence likely reflects screening effects—widespread colonoscopy programs among older adults reduce incidence through detection and removal of precancerous lesions, while younger adults remain largely unscreened. Conversely, cancers such as liver, oral, esophageal, and stomach decreased among younger adults in more than half of the countries, demonstrating regional improvements in infection control, tobacco reduction, or dietary shifts.
Geographically, trends were consistent across continents: thyroid and kidney cancer increased widely, while upper gastrointestinal cancers declined. Patterns were also similar between sexes. These results challenge the popular narrative of a discrete “young adult cancer crisis,” emphasizing instead a global rise in cancer across the adult age spectrum.
Interpretation and Context
The authors argue that shared risk factors, notably obesity, diet, and metabolic disease, likely drive parallel increases in younger and older adults. Endometrial and kidney cancers—both strongly linked to obesity—showed consistent uptrends in all regions. Nonetheless, the study acknowledges data limitations: most registries were from high- and middle-income countries, and the analysis extended only to 2017. Still, this work provides vital international evidence to inform research priorities, prevention strategies, and clinical screening guidelines.
The authors caution against disproportionate focus on early-onset cancer. Although relative increases are steeper among young adults, absolute numbers remain much higher in older adults, who account for most global cases. For instance, in the U.S. (2022), roughly 210,000 colorectal and 210,000 breast cancers occurred in adults ≥50 years, compared with 21,000 and 50,000, respectively, in those under 50. Thus, public health responses should balance attention between early detection in younger populations and sustained cancer control for aging adults.
Editorial Perspective
Cann and Dotan’s editorial situates the findings within a broader clinical and societal framework. They emphasize that rising cancer incidence spans both young and old, warranting the phrase “generations at risk.” They highlight distinct challenges: younger adults often face aggressive disease, overtreatment, and psychosocial burdens—such as disruptions to career, fertility, and identity—while older adults are vulnerable to undertreatment and treatment-related toxicity due to comorbidities and frailty. Both groups, however, remain underrepresented in clinical trials, limiting evidence-based care across the lifespan.
The editorial underscores urgent research into the “global exposome”—the cumulative lifetime exposure to environmental and behavioral carcinogens—and calls for better integration of geriatric assessment in oncology, as well as dedicated programs for adolescent and young adult (AYA) cancer care.
It warns of the projected $25 trillion global economic cost of cancer care by 2050, compounded by workforce shortages in oncology.
Conclusion
Together, the article and editorial reframe the conversation about early-onset cancer. The global increase in cancer incidence is not limited to youth, but reflects a shared, multigenerational phenomenon driven by lifestyle, environmental, and demographic shifts. As both younger and older adults increasingly face cancer, a unified, age-inclusive approach to prevention, research, and treatment will be essential to address what the editorial aptly calls “a global cancer challenge spanning generations.
”Reference: Downloaded from https://annals.org by Providence Health and Services Libraries on 10/21/2025.
